[68Ga]Ga-PSMA PET/MRI, histological PSMA expression and preliminary experience with [177Lu]Lu-PSMA therapy in relapsing high-grade glioma

Autor: Peter Truckenmueller, Josefine Graef, Michael Scheel, Peter Vajkoczy, David Capper, David Kaul, Christian Furth, Holger Amthauer, Winfried Brenner, Julia Sophie Onken

Publikováno v: Frontiers in Oncology, Vol 12 (2022)

PurposeHigh-grade gliomas (HGG) are still associated with a dismal prognosis. Prostate specific membrane antigen (PSMA) is discussed as a theranostic target for PSMA-directed radioligand therapy ([177Lu]Lu-PSMA RLT). Here, we report on the correlatio

Externí odkaz: https://doaj.org/article/6349e0f478a34846a0f008b126d101f0

Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021

Autor: Silke Gillessen, Andrew Armstrong, Gert Attard, Tomasz M. Beer, Himisha Beltran, Anders Bjartell, Alberto Bossi, Alberto Briganti, Robert G. Bristow, Muhammad Bulbul, Orazio Caffo, Kim N. Chi, Caroline S. Clarke, Noel Clarke, Ian D. Davis, Johann S. de Bono, Ignacio Duran, Ros Eeles, Eleni Efstathiou, Jason Efstathiou, Onyeanunam Ngozi Ekeke, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Karim Fizazi, Mark Frydenberg, Dan George, Martin Gleave, Susan Halabi, Daniel Heinrich, Celesta Higano, Michael S. Hofman, Maha Hussain, Nick James, Robert Jones, Ravindran Kanesvaran, Raja B. Khauli, Laurence Klotz, Raya Leibowitz, Chris Logothetis, Fernando Maluf, Robin Millman, Alicia K. Morgans, Michael J. Morris, Nicolas Mottet, Hind Mrabti, Declan G. Murphy, Vedang Murthy, William K. Oh, Piet Ost, Joe M. O'Sullivan, Anwar R. Padhani, Chris Parker, Darren M.C. Poon, Colin C. Pritchard, Danny M. Rabah, Dana Rathkopf, Rob E. Reiter, Mark Rubin, Charles J. Ryan, Fred Saad, Juan P. Sade, Oliver Sartor, Howard I. Scher, Neal Shore, Iwona Skoneczna, Eric Small, Matthew Smith, Howard Soule, Daniel E. Spratt, Cora N. Sternberg, Hiroyoshi Suzuki, Christopher Sweeney, Matthew R. Sydes, Mary-Ellen Taplin, Derya Tilki, Bertrand Tombal, Levent Türkeri, Hiroji Uemura, Hirotsugu Uemura, Inge van Oort, Kosj Yamoah, Dingwei Ye, Almudena Zapatero, Aurelius Omlin

Publikováno v: European Urology, Vol. 82, no. 1, p. 115-141 (2022)
European Urology, 82, 1, pp. 115-141
European Urology, 82, 115-141
Gillessen, S, Armstrong, A, Attard, G, Beer, T M, Beltran, H, Bjartell, A, Bossi, A, Briganti, A, Bristow, R G, Bulbul, M, Caffo, O, Chi, K N, Clarke, C S, Clarke, N, Davis, I D, de Bono, J S, Duran, I, Eeles, R, Efstathiou, E, Efstathiou, J, Ekeke, O N, Evans, C P, Fanti, S, Feng, F Y, Fizazi, K, Frydenberg, M, George, D, Gleave, M, Halabi, S, Heinrich, D, Higano, C, Hofman, M S, Hussain, M, James, N, Jones, R, Kanesvaran, R, Khauli, R B, Klotz, L, Leibowitz, R, Logothetis, C, Maluf, F, Millman, R, Morgans, A K, Morris, M J, Mottet, N, Mrabti, H, Murphy, D G, Murthy, V, Oh, W K, Ost, P, O'Sullivan, J M, Padhani, A R, Parker, C, Poon, D M C, Pritchard, C C, Rabah, D M, Rathkopf, D, Reiter, R E, Rubin, M, Ryan, C J, Saad, F, Sade, J P, Sartor, O, Scher, H I, Shore, N, Skoneczna, I, Small, E, Smith, M, Soule, H, Spratt, D E, Sternberg, C N, Suzuki, H, Sweeney, C, Sydes, M R, Taplin, M-E, Tilki, D, Tombal, B, Türkeri, L, Uemura, H, Uemura, H, van Oort, I, Yamoah, K, Ye, D, Zapatero, A & Omlin, A 2022, ' Management of Patients with Advanced Prostate Cancer : Report from the Advanced Prostate Cancer Consensus Conference 2021 ', European Urology, vol. 82, no. 1, pp. 115-141 . https://doi.org/10.1016/j.eururo.2022.04.002
Gillessen, S, Armstrong, A, Attard, G, Beer, T M, Beltran, H, Bjartell, A, Bossi, A, Briganti, A, Bristow, R G, Bulbul, M, Caffo, O, Chi, K N, Clarke, C S, Clarke, N, Davis, I D, de Bono, J S, Duran, I, Eeles, R, Efstathiou, E, Efstathiou, J, Ekeke, O N, Evans, C P, Fanti, S, Feng, F Y, Fizazi, K, Frydenberg, M, George, D, Gleave, M, Halabi, S, Heinrich, D, Higano, C, Hofman, M S, Hussain, M, James, N, Jones, R, Kanesvaran, R, Khauli, R B, Klotz, L, Leibowitz, R, Logothetis, C, Maluf, F, Millman, R, Morgans, A K, Morris, M J, Mottet, N, Mrabti, H, Murphy, D G, Murthy, V, Oh, W K, Ost, P, O'Sullivan, J M, Padhani, A R, Parker, C, Poon, D M C, Pritchard, C C, Rabah, D M, Rathkopf, D, Reiter, R E, Rubin, M, Ryan, C J, Saad, F, Sade, J P, Sartor, O, Scher, H I, Shore, N, Skoneczna, I, Small, E, Smith, M, Soule, H, Spratt, D E, Sternberg, C N, Suzuki, H, Sweeney, C, Sydes, M R, Taplin, M-E, Tilki, D, Tombal, B, Türkeri, L, Uemura, H, Uemura, H, van Oort, I, Yamoah, K, Ye, D, Zapatero, A & Omlin, A 2022, ' Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021 ', European urology, vol. 82, no. 1, pp. 115-141 . https://doi.org/10.1016/j.eururo.2022.04.002
European Urology

Background: innovations in treatments, imaging, and molecular characterisation in advanced prostate cancer have improved outcomes, but various areas of management still lack high-level evidence to inform clinical practice. The 2021 Advanced Prostate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cffc45bb1dc31fcb1cb0b57de6753615
https://hdl.handle.net/2078.1/260304

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021.

Autor: Gillessen S; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Universita della Svizzera Italiana, Lugano, Switzerland; University of Berne, Berne, Switzerland; Division of Cancer Sciences, University of Manchester, Manchester, UK. Electronic address: silke.gillessen@eoc.ch., Armstrong A; Duke Cancer Institute Center for Prostate and Urologic Cancers, Durham, NC, USA., Attard G; University College London Cancer Institute, London, UK., Beer TM; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA., Beltran H; Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Bjartell A; Department of Urology, Skåne University Hospital, Malmö, Sweden., Bossi A; Genitourinary Oncology, Prostate Brachytherapy Unit, Gustave Roussy, Paris, France., Briganti A; Unit of Urology/Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy., Bristow RG; Division of Cancer Sciences, University of Manchester, Manchester, UK; Christie NHS Trust and CRUK Manchester Institute and Cancer Centre, Manchester, UK., Bulbul M; Division of Urology, Department of Surgery, American University of Beirut Medical Center, Beirut, Lebanon., Caffo O; Department of Medical Oncology, Santa Chiara Hospital, Trento, Italy., Chi KN; BC Cancer, Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada., Clarke CS; Research Department of Primary Care & Population Health, Royal Free Campus, University College London, London, UK., Clarke N; The Christie and Salford Royal Hospitals, Manchester, UK., Davis ID; Monash University and Eastern Health, Victoria, Australia., de Bono JS; The Institute of Cancer Research, Royal Marsden NHS Foundation Trust, Sutton, UK., Duran I; Department of Medical Oncology, Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Spain., Eeles R; The Institute of Cancer Research, Royal Marsden NHS Foundation Trust, Sutton, UK., Efstathiou E; Houston Methodist Cancer Center, Houston, TX, USA., Efstathiou J; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA., Ekeke ON; Department of Surgery, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria., Evans CP; University of California Davis School of Medicine, Sacramento, CA, USA., Fanti S; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Feng FY; UCSF Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, CA, USA., Fizazi K; Institut Gustave Roussy, University of Paris Saclay, Villejuif, France., Frydenberg M; Department of Surgery, Prostate Cancer Research Program, Monash University, Melbourne, Australia., George D; Departments of Medicine and Surgery, Duke Cancer Institute, Duke University, Durham, NC, USA., Gleave M; Urological Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada., Halabi S; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA., Heinrich D; Department of Oncology and Radiotherapy, Innlandet Hospital Trust, Gjøvik, Norway., Higano C; University of British Columbia, Vancouver, BC, Canada., Hofman MS; Prostate Cancer Theranostics and Imaging Centre of Excellence, Department of Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Hussain M; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA., James N; The Institute of Cancer Research, Royal Marsden NHS Foundation Trust, Sutton, UK., Jones R; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Kanesvaran R; Division of Medical Oncology, National Cancer Centre, Singapore., Khauli RB; Department of Urology and the Naef K. Basile Cancer Institute, American University of Beirut Medical Center, Beirut, Lebanon., Klotz L; Division of Urology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada., Leibowitz R; Oncology Institute, Shamir Medical Center and Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel., Logothetis C; Department of Genitourinary Medical Oncology, David H. Koch Centre, MD Anderson Cancer Centre, Houston, TX, USA; Department of Clinical Therapeutics, University of Athens Alexandra Hospital, Athens, Greece., Maluf F; Beneficiência Portuguesa de São Paulo, São Paulo, SP, Brazil; Departamento de Oncologia, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Millman R; Patient Advocate, UK., Morgans AK; Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Morris MJ; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mottet N; University Jean Monnet, St. Etienne, France., Mrabti H; National Institute of Oncology, Mohamed V University, Rabat, Morocco., Murphy DG; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia., Murthy V; Tata Memorial Centre, Mumbai, India., Oh WK; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute, New York, NY, USA., Ost P; Department of Radiation Oncology, Iridium Netwerk, Antwerp, Belgium; Department of Human Structure and Repair, Ghent University, Ghent, Belgium., O'Sullivan JM; Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Northern Ireland Cancer Centre, Belfast City Hospital, Belfast, UK., Padhani AR; The Institute of Cancer Research, Royal Marsden NHS Foundation Trust, Sutton, UK; Mount Vernon Cancer Centre, London, UK., Parker C; The Institute of Cancer Research, Royal Marsden NHS Foundation Trust, Sutton, UK., Poon DMC; Comprehensive Oncology Centre, Hong Kong Sanatorium & Hospital, The Chinese University of Hong Kong, Hong Kong., Pritchard CC; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA., Rabah DM; The Cancer Research Chair, College of Medicine, King Saud University, Riyadh, Saudi Arabia., Rathkopf D; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Reiter RE; University of California-Los Angeles, Los Angeles, CA, USA., Rubin M; Bern Center for Precision Medicine and Department for Biomedical Research, Bern, Switzerland., Ryan CJ; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA., Saad F; Centre Hospitalier de Université de Montréal, Montreal, Canada., Sade JP; Instituto Alexander Fleming, Buenos Aires, Argentina., Sartor O; Tulane Cancer Center, New Orleans, LA, USA., Scher HI; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Shore N; Carolina Urologic Research Center, Myrtle Beach, SC, USA., Skoneczna I; Rafal Masztak Grochowski Hospital and Maria Sklodowska Curie National Research Institute of Oncology, Warsaw, Poland., Small E; UCSF Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, CA, USA., Smith M; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Soule H; Prostate Cancer Foundation, Santa Monica, CA, USA., Spratt DE; University Hospitals Seidman Cancer Center, Cleveland, OH, USA., Sternberg CN; Englander Institute for Precision Medicine, Weill Cornell Medicine Division of Hematology and Oncology, Meyer Cancer Center, New York Presbyterian Hospital, New York, NY, USA., Suzuki H; Toho University Sakura Medical Center, Chiba, Japan., Sweeney C; Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Sydes MR; MRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK., Taplin ME; Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Tilki D; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, Koc University Hospital, Istanbul, Turkey., Tombal B; Cliniques Universitaires Saint Luc, Brussels, Belgium., Türkeri L; Department of Urology, M.A. Aydınlar Acıbadem University, Altunizade Hospital, Istanbul, Turkey., Uemura H; Yokohama City University Medical Center, Yokohama, Japan., Uemura H; Department of Urology, Kindai University Faculty of Medicine, Osaka, Japan., van Oort I; Radboud University Medical Center, Nijmegen, The Netherlands., Yamoah K; Department of Radiation Oncology & Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, University of South Florida, Tampa, FL, USA., Ye D; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Zapatero A; Department of Radiation Oncology, Hospital Universitario de La Princesa, Health Research Institute, Madrid, Spain., Omlin A; Department of Medical Oncology and Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.

Publikováno v: European urology [Eur Urol] 2022 Jul; Vol. 82 (1), pp. 115-141. Date of Electronic Publication: 2022 Apr 18.